Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury
dc.article.number | 31622 | |
dc.contributor.author | Suber, Tomeka L. | |
dc.contributor.author | Tabary, Mohammadreza | |
dc.contributor.author | Bain, William | |
dc.contributor.author | Olonisakin, Tolani | |
dc.contributor.author | Lockwood, Karina | |
dc.contributor.author | Xiong, Zeyu | |
dc.contributor.author | Zhang, Yingze | |
dc.contributor.author | Kohli, Naina | |
dc.contributor.author | Furguiele, Lauren | |
dc.contributor.author | Peñaloza Cerda, Hernán Felipe | |
dc.contributor.author | Mcverry, Bryan J. | |
dc.contributor.author | Rose, Jason J. | |
dc.contributor.author | Shah, Faraaz | |
dc.contributor.author | Methe, Barbara | |
dc.contributor.author | Li, Kelvin | |
dc.contributor.author | Mallampalli, Rama K. | |
dc.contributor.author | Chen, Kong | |
dc.contributor.author | Fan, Li | |
dc.contributor.author | Morris, Alison | |
dc.contributor.author | Tyurin, Vladimir A. | |
dc.contributor.author | Samovich, Svetlana N. | |
dc.contributor.author | Bayir, Hulya | |
dc.contributor.author | Tyurina, Yulia Y. | |
dc.contributor.author | Kagan, Valerian | |
dc.contributor.author | Lee, Janet S. | |
dc.date.accessioned | 2025-05-15T10:30:02Z | |
dc.date.available | 2025-05-15T10:30:02Z | |
dc.date.issued | 2024 | |
dc.description.abstract | E-cigarette/vaping-associated lung injury (EVALI) is strongly associated with vitamin E acetate and often occurs with concomitant tetrahydrocannabinol (THC) use. To uncover pathways associated with EVALI, we examined cytokines, transcriptomic signatures, and lipidomic profiles in bronchoalveolar lavage fluid (BALF) from THC-EVALI patients. At a single center, we prospectively enrolled mechanically ventilated patients with EVALI from THC-containing products (N = 4) and patients with non-vaping acute lung injury and airway controls (N = 5). BALF samples were analyzed by Luminex multiplex assay, RNA sequencing, and mass spectrometry. After treating BEAS-2B lung epithelial cells with vaping and non-vaping BALF, LDH release was quantified. THC-EVALI BALF had significant increases in IFN gamma, CCL2, CXCL5, and MMP2 relative to non-vaping patients. RNA sequencing showed enrichment for biological oxidation, glucuronidation, and fatty acid metabolism pathways. Oleic acid and arachidonic acid metabolites were increased in THC-EVALI, as were oxidized phosphatidylethanolamines (PE) such as PE(38:4). THC-EVALI BALF induced more LDH release compared to BALF from non-vaping patients. Thus, THC-EVALI is characterized by altered phospholipid composition, accumulation of lipid oxidation products, and increased pro-inflammatory mediators that may contribute to epithelial cell death. These findings serve as a framework to study novel oxidized phospholipids implicated in the pathogenesis of EVALI. | |
dc.description.funder | National Institutes of Health | |
dc.format.extent | 15 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1038/s41598-024-79585-8 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | https://doi.org/10.1038/s41598-024-79585-8 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/104254 | |
dc.identifier.wosid | WOS:001389341300016 | |
dc.information.autoruc | Facultad de Ciencias Biológicas; Peñaloza Cerda, Hernán Felipe; S/I; 186994 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.revista | SCIENTIFIC REPORTS | |
dc.rights | acceso restringido | |
dc.subject | Lipidomics | |
dc.subject | Vaping | |
dc.subject | Acute lung injury | |
dc.subject | Phospholipids | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury | |
dc.type | artículo | |
dc.volumen | 14 | |
sipa.codpersvinculados | 186994 | |
sipa.index | WOS | |
sipa.trazabilidad | Carga WOS-SCOPUS;15-05-2025 |